Araceli Biosciences
Araceli Biosciences reported $2,526,065 raised in an SEC Form D filed on 2026-11-03. State of the filing: Oregon.
- Industry
- Other Technology
- Location
- Oregon
About
Araceli Biosciences filed an SEC Form D on 2026-11-03. The filing reports $2,526,065 raised and gives Oregon as the state. The industry on the filing is Other Technology. Related persons named on the filing: Matt Beaudet (executive officer, director, Tigard, Oregon); Shawn MacDonald (executive officer, Tigard, Oregon); William Cortelyou (director, Tigard, Oregon); J. William Freytag (director, Tigard, Oregon); Kirk Malloy (director, Tigard, Oregon); Sean O'Neill (director, Tigard, Oregon); Samraat Raha (director, Tigard, Oregon); Bruce Rhine (director, Tigard, Oregon); Christine Ann Tsingos (director, Tigard, Oregon). The legal name on the form is Araceli Biosciences Inc. Filing: https://www.sec.gov/Archives/edgar/data/1975014/000197501426000004/0001975014-26-000004-index.htm
Year of incorporation on the form: 2022. Securities on the form: debt; option, warrant or other right to acquire another security; security to be acquired upon exercise of option, warrant or other right. That wording is not stored as a round type. Earlier Form D filings, if any, are not combined. The issuer city on the form is Tigard. It is not stored as a headquarters.
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-11-03 | $2.53M |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/1975014/000197501426000004/0001975014-26-000004-index.htm
Type: sec filing. Accessed 2026-11-04.
SEC Form D for Araceli Biosciences Inc. EDGAR filing date 2026-11-03. Acceptance time on the index page: 2026-11-03 12:25:39. Signed 2026-11-03 by Matt Beaudet, Chief Executive Officer. First sale 2026-10-20. A new notice, not an amendment. Total amount sold $2,526,065 of an offering amount of $4,500,000. 4 investors already invested. Issuer address city is Tigard, Oregon. Jurisdiction on the form: Delaware. Entity type on the form: Corporation. Year of incorporation on the form: 2022. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. Securities on the form: debt; option, warrant or other right to acquire another security; security to be acquired upon exercise of option, warrant or other right. That wording is not stored as a round type. Related persons use the names in the issue. Earlier Form D filings, if any, are not combined. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-11-04/
Type: other verified public source. Accessed 2026-11-04.
Raise Track Update for 2026-11-04, Section 3. Lists Araceli Biosciences in Oregon, industry Other Technology, amount raised $2,526,065.